electroCore (ECOR) Income from Non-Controlling Interests (2017 - 2018)
electroCore's (ECOR) quarterly Income from Non-Controlling Interests came in at $55005.0 in Q1 2018, up 123.89% quarter-over-quarter from -$230218.0 in Q4 2017.
electroCore (ECOR) Income from Non-Controlling Interests (2017 - 2018) Analysis & Trends
electroCore's Income from Non-Controlling Interests history runs 2 years deep, the most recent figure standing at $55005.0 for Q1 2018.
- On a quarterly basis, Income from Non-Controlling Interests changed N/A year-over-year to $55005.0 in Q1 2018; TTM through Dec 2018 was $55005.0, a N/A change from a year earlier, with the FY2018 full-year figure at $55005.0, up 123.27% from the prior year.
- Income from Non-Controlling Interests rose to $55005.0 in Q1 2018 per ECOR's latest filing, from -$230218.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $55005.0 in Q1 2018 and bottomed at -$230218.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -5.85 Mn |
| 10 | electroCore | 55,642.90 | -8.77 Mn | 8.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 55,005.00 |
| Dec 31, 2017 | -230,218.00 |
| Sep 30, 2017 | -95.00 |
| Jun 30, 2017 | -6,045.00 |